{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:18:01Z","timestamp":1787602681363,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition Research"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.nutres.2010.09.009","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T08:40:08Z","timestamp":1288946408000},"page":"678-688","source":"Crossref","is-referenced-by-count":43,"title":["Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome"],"prefix":"10.1016","volume":"30","author":[{"given":"David M.","family":"Christmas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla A.-B.","family":"Badawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.C.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Probert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Creed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Smithson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Potokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nutres.2010.09.009_bb0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000048862","article-title":"Epidemiological aspects of irritable bowel syndrome in Europe and North America","volume":"64","author":"Muller-Lissner","year":"2001","journal-title":"Digestion"},{"issue":"6","key":"10.1016\/j.nutres.2010.09.009_bb0010","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1365-2036.1997.00262.x","article-title":"Clinical economics review: irritable bowel syndrome","volume":"11","author":"Wells","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000007593","article-title":"Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom","volume":"60","author":"Hahn","year":"1999","journal-title":"Digestion"},{"issue":"9","key":"10.1016\/j.nutres.2010.09.009_bb0020","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/BF01303162","article-title":"U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact","volume":"38","author":"Drossman","year":"1993","journal-title":"Dig Dis Sci"},{"issue":"9332","key":"10.1016\/j.nutres.2010.09.009_bb0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(02)09712-X","article-title":"Irritable bowel syndrome: a little understood organic bowel disease?","volume":"360","author":"Talley","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.nutres.2010.09.009_bb0030","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/gast.2002.32392","article-title":"Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?","volume":"122","author":"Whitehead","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.nutres.2010.09.009_bb0035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2005.11.033","article-title":"Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?","volume":"130","author":"Dinan","year":"2006","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.nutres.2010.09.009_bb0040","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1136\/gut.2004.041657","article-title":"Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls","volume":"53","author":"Kilkens","year":"2004","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.nutres.2010.09.009_bb0045","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.1365-2036.2002.01287.x","article-title":"The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients","volume":"16","author":"Mayer","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.nutres.2010.09.009_bb0050","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2036.2008.03721.x","article-title":"Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study","volume":"28","author":"Jarcho","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.nutres.2010.09.009_bb0055","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tips.2008.05.004","article-title":"Serotonin and depression: pathophysiological mechanism or marketing myth?","volume":"29","author":"Cowen","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"2 Suppl","key":"10.1016\/j.nutres.2010.09.009_bb0060","first-page":"24S","article-title":"Sleep and serotonin: an unfinished story","volume":"21","author":"Jouvet","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/026988110201600116","article-title":"Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine","volume":"16","author":"Bell","year":"2002","journal-title":"J Psychopharmacol"},{"issue":"6","key":"10.1016\/j.nutres.2010.09.009_bb0070","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/0269881105059253","article-title":"Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology","volume":"19","author":"Baldwin","year":"2005","journal-title":"J Psychopharmacol"},{"issue":"4","key":"10.1016\/j.nutres.2010.09.009_bb0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0269881107088441","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines","volume":"22","author":"Anderson","year":"2008","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tins.2006.11.002","article-title":"5-HT in the enteric nervous system: gut function and neuropharmacology","volume":"30","author":"McLean","year":"2007","journal-title":"Trends Neurosci"},{"issue":"Suppl 2","key":"10.1016\/j.nutres.2010.09.009_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2036.1999.00002.x-i2","article-title":"Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel","volume":"13","author":"Gershon","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.nutres.2010.09.009_bb0095","doi-asserted-by":"crossref","first-page":"i81","DOI":"10.1136\/gut.51.suppl_1.i81","article-title":"Serotonergic modulation of visceral sensation: lower gut","volume":"51","author":"Camilleri","year":"2002","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.nutres.2010.09.009_bb0100","doi-asserted-by":"crossref","first-page":"i77","DOI":"10.1136\/gut.51.suppl_1.i77","article-title":"Serotonergic modulation of visceral sensation: upper gastrointestinal tract","volume":"51","author":"Tack","year":"2002","journal-title":"Gut"},{"issue":"4-5","key":"10.1016\/j.nutres.2010.09.009_bb0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1438-4221(00)80073-9","article-title":"Enterotoxins and the enteric nervous system\u2014a fatal attraction","volume":"290","author":"Farthing","year":"2000","journal-title":"Int J Med Microbiol"},{"issue":"7","key":"10.1016\/j.nutres.2010.09.009_bb0110","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/pds.1596","article-title":"Common adverse events associated with an SSRI: meta-analysis of early paroxetine data","volume":"17","author":"Aursnes","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2005.09.031","article-title":"Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome","volume":"130","author":"Atkinson","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.nutres.2010.09.009_bb0120","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/cs0940663","article-title":"Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans","volume":"94","author":"Lordal","year":"1998","journal-title":"Clin Sci (Lond)"},{"issue":"9","key":"10.1016\/j.nutres.2010.09.009_bb0125","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1046\/j.1365-2036.1999.00610.x","article-title":"Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist","volume":"13","author":"Camilleri","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.nutres.2010.09.009_bb0130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2036.1996.30172000.x","article-title":"Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?","volume":"10","author":"Maxton","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.nutres.2010.09.009_bb0135","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1572-0241.2003.07542.x","article-title":"Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome","volume":"98","author":"Dunlop","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.nutres.2010.09.009_bb0140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0021-9258(18)71332-X","article-title":"The amino acid requirement of man","volume":"206","author":"Rose","year":"1950","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0145","first-page":"CD003198","article-title":"Tryptophan and 5-hydroxytryptophan for depression","author":"Shaw","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.nutres.2010.09.009_bb0150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/j.1440-1614.2005.01628.x","article-title":"Acute tryptophan depletion. Part II: clinical effects and implications","volume":"39","author":"Bell","year":"2005","journal-title":"Aust N Z J Psychiatry"},{"issue":"5","key":"10.1016\/j.nutres.2010.09.009_bb0155","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archpsyc.1990.01810170011002","article-title":"Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan","volume":"47","author":"Delgado","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"10.1016\/j.nutres.2010.09.009_bb0160","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1111\/j.1572-0241.2006.00811.x","article-title":"Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome","volume":"101","author":"Shufflebotham","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.nutres.2010.09.009_bb0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development","volume":"1","author":"Stone","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"20","key":"10.1016\/j.nutres.2010.09.009_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000068","article-title":"Tryptophan metabolism in the central nervous system: medical implications","volume":"8","author":"Ruddick","year":"2006","journal-title":"Expert Rev Mol Med"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1079\/NRR200133","article-title":"Tryptophan metabolism in alcoholism","volume":"15","author":"Badawy","year":"2002","journal-title":"Nutr Res Rev"},{"issue":"11","key":"10.1016\/j.nutres.2010.09.009_bb0180","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","article-title":"Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism","volume":"5","author":"Taylor","year":"1991","journal-title":"FASEB J"},{"issue":"Pt 5","key":"10.1016\/j.nutres.2010.09.009_bb0185","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease","volume":"115","author":"Heyes","year":"1992","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.nutres.2010.09.009_bb0190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1179\/135100099101534927","article-title":"Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway","volume":"4","author":"Thomas","year":"1999","journal-title":"Redox Rep"},{"issue":"12","key":"10.1016\/j.nutres.2010.09.009_bb0195","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1365-2982.2008.01195.x","article-title":"Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity","volume":"20","author":"Fitzgerald","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.nutres.2010.09.009_bb0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-9-6","article-title":"Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort","volume":"9","author":"Clarke","year":"2009","journal-title":"BMC Gastroenterol"},{"issue":"24","key":"10.1016\/j.nutres.2010.09.009_bb0205","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/0024-3205(89)90114-8","article-title":"Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects","volume":"45","author":"Delgado","year":"1989","journal-title":"Life Sci"},{"issue":"9","key":"10.1016\/j.nutres.2010.09.009_bb0210","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/ajcn\/32.9.1912","article-title":"Diurnal variations in plasma concentrations of tryptophan, tryosine, and other neutral amino acids: effect of dietary protein intake","volume":"32","author":"Fernstrom","year":"1979","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00806091","article-title":"l-Tryptophan: biochemical, nutritional and pharmacological aspects","volume":"10","author":"Sainio","year":"1996","journal-title":"Amino Acids"},{"issue":"11","key":"10.1016\/j.nutres.2010.09.009_bb0220","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/j.1572-0241.1998.00531.x","article-title":"Are adverse food reactions linked to irritable bowel syndrome?","volume":"93","author":"Niec","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/oxfordjournals.aje.a117548","article-title":"Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization","volume":"142","author":"Talley","year":"1995","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.nutres.2010.09.009_bb0230","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00213-008-1163-2","article-title":"Comparison of 50- and 100-g l-tryptophan depletion and loading formulations for altering 5-HT synthesis: pharmacokinetics, side effects, and mood states","volume":"198","author":"Dougherty","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"6138","key":"10.1016\/j.nutres.2010.09.009_bb0235","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bmj.2.6138.653","article-title":"Towards positive diagnosis of the irritable bowel","volume":"2","author":"Manning","year":"1978","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.nutres.2010.09.009_bb0240","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00726-007-0012-7","article-title":"Application of the Phenomenex EZ:faasttrade mark amino acid analysis kit for rapid gas-chromatographic determination of concentrations of plasma tryptophan and its brain uptake competitors","volume":"34","author":"Badawy","year":"2008","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.nutres.2010.09.009_bb0245","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0003-2697(74)90275-9","article-title":"Error in the determination of tryptophan by the method of Denkla and Dewey. A revised procedure","volume":"60","author":"Bloxam","year":"1974","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0250","first-page":"160","article-title":"The determination of tryptophan in plasma, liver, and urine","volume":"69","author":"Denckla","year":"1967","journal-title":"J Lab Clin Med"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/bj1580079","article-title":"Animal liver tryptophan pyrrolases: absence of apoenzyme and of hormonal induction mechanism from species sensitive to tryptophan toxicity","volume":"158","author":"Badawy","year":"1976","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.nutres.2010.09.009_bb0260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/alcalc\/agp005","article-title":"Activation of liver tryptophan pyrrolase mediates the decrease in tryptophan availability to the brain after acute alcohol consumption by normal subjects","volume":"44","author":"Badawy","year":"2009","journal-title":"Alcohol Alcohol"},{"issue":"Pt 2","key":"10.1016\/j.nutres.2010.09.009_bb0265","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/000456329403100215","article-title":"Effects of storage on binding and stability of tryptophan in human serum","volume":"31","author":"Morgan","year":"1994","journal-title":"Ann Clin Biochem"},{"issue":"5","key":"10.1016\/j.nutres.2010.09.009_bb0270","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00006199-198909000-00006","article-title":"Visual analogue scales: measurement of subjective phenomena","volume":"38","author":"Gift","year":"1989","journal-title":"Nurs Res"},{"key":"10.1016\/j.nutres.2010.09.009_bb0275","series-title":"Manual for the Depression Anxiety Stress Scales","author":"Lovibond","year":"1995"},{"issue":"Pt 2","key":"10.1016\/j.nutres.2010.09.009_bb0280","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1348\/014466503321903544","article-title":"The Depression Anxiety Stress Scales (DASS): normative data and latent structure in a large non-clinical sample","volume":"42","author":"Crawford","year":"2003","journal-title":"Br J Clin Psychol"},{"issue":"4","key":"10.1016\/j.nutres.2010.09.009_bb0285","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1445-5994.1995.tb01894.x","article-title":"Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians","volume":"25","author":"Talley","year":"1995","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.nutres.2010.09.009_bb0290","article-title":"Plasma free tryptophan revisited: what you need to know and do before measuring it","author":"Badawy","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0295","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/10253890801976926","article-title":"Women with diarrhoea-predominant irritable bowel syndrome show an increased pressure response to 35% carbon dioxide stress challenge","volume":"12","author":"Shufflebotham","year":"2009","journal-title":"Stress"},{"issue":"13","key":"10.1016\/j.nutres.2010.09.009_bb0300","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1016\/S0021-9258(19)41270-2","article-title":"Tryptophan catabolism by tryptophan pyrrolase in rat liver. The effect of tryptophan loads and changes in tryptophan pyrrolase activity","volume":"250","author":"Young","year":"1975","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nutres.2010.09.009_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: disease and healthy states","volume":"2","author":"Chen","year":"2009","journal-title":"Int J Tryptophan Res"},{"key":"10.1016\/j.nutres.2010.09.009_bb0310","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ics.2007.07.034","article-title":"Assessment of the kynurenine pathway in humans: I. Normal plasma values, ethnic differences and their clinical implications","volume":"1304","author":"Badawy","year":"2007","journal-title":"Int Congr Series"},{"issue":"2","key":"10.1016\/j.nutres.2010.09.009_bb0315","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0098-2997(83)90005-5","article-title":"Biochemistry of tryptophan in health and disease","volume":"6","author":"Bender","year":"1983","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.nutres.2010.09.009_bb0320","first-page":"159","article-title":"Kynurenine pathway metabolites in serum of patients with irritable bowel syndrome - possible role in the mechanism of visceral pain","volume":"13","author":"Wollny","year":"2006","journal-title":"Gastroenterol Pol"},{"issue":"3","key":"10.1016\/j.nutres.2010.09.009_bb0325","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jir.1986.6.267","article-title":"Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts","volume":"6","author":"Pfefferkorn","year":"1986","journal-title":"J Interferon Res"},{"issue":"5","key":"10.1016\/j.nutres.2010.09.009_bb0330","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1515\/bchm3.1988.369.1.337","article-title":"Tryptophan degradation in patients infected by human immunodeficiency virus","volume":"369","author":"Werner","year":"1988","journal-title":"Biol Chem Hoppe Seyler"},{"issue":"9","key":"10.1016\/j.nutres.2010.09.009_bb0335","first-page":"873","article-title":"Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic\/psychiatric symptoms","volume":"3","author":"Fuchs","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.nutres.2010.09.009_bb0340","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/jir.1990.10.599","article-title":"Immune activation and decreased tryptophan in patients with HIV-1 infection","volume":"10","author":"Fuchs","year":"1990","journal-title":"J Interferon Res"},{"issue":"3","key":"10.1016\/j.nutres.2010.09.009_bb0345","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0165-1838(95)00043-W","article-title":"Expression of mRNA for the N-methyl-d-aspartate (NMDAR1) receptor and vasoactive intestinal polypeptide (VIP) co-exist in enteric neurons of the rat","volume":"55","author":"Burns","year":"1995","journal-title":"J Auton Nerv Syst"},{"issue":"12","key":"10.1016\/j.nutres.2010.09.009_bb0350","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1523\/JNEUROSCI.17-12-04764.1997","article-title":"Glutamatergic enteric neurons","volume":"17","author":"Liu","year":"1997","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.nutres.2010.09.009_bb0355","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.nutres.2010.09.009_bb0360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2982.2007.00989.x","article-title":"Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs","volume":"20","author":"Kaszaki","year":"2008","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"10.1016\/j.nutres.2010.09.009_bb0365","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00726-007-0631-z","article-title":"Micromolar concentration of kynurenic acid in rat small intestine","volume":"35","author":"Kuc","year":"2008","journal-title":"Amino Acids"},{"issue":"4","key":"10.1016\/j.nutres.2010.09.009_bb0370","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00726-008-0183-x","article-title":"High concentration of kynurenic acid in bile and pancreatic juice","volume":"37","author":"Paluszkiewicz","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.nutres.2010.09.009_bb0375","unstructured":"Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis. [WO\/2008\/087461]. 2008. World Intellectual Property Organization. Ref Type: Patent."},{"issue":"3","key":"10.1016\/j.nutres.2010.09.009_bb0380","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/bj2170863","article-title":"High-fat diets increase tryptophan availability to the brain: importance of choice of the control diet","volume":"217","author":"Badawy","year":"1984","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.nutres.2010.09.009_bb0385","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0898264309340693","article-title":"Long-term fish intake is associated with less severe depressive symptoms among elderly men and women: the MEDIS (MEDiterranean ISlands Elderly) epidemiological study","volume":"21","author":"Bountziouka","year":"2009","journal-title":"J Aging Health"},{"issue":"3","key":"10.1016\/j.nutres.2010.09.009_bb0390","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.plefa.2008.01.003","article-title":"Association of fish and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive episodes in middle-aged French men and women","volume":"78","author":"Astorg","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"10.1016\/j.nutres.2010.09.009_bb0395","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/070674370805300407","article-title":"Lifestyle characteristics of psychiatric outpatients","volume":"53","author":"Chuang","year":"2008","journal-title":"Can J Psychiatry"},{"issue":"7","key":"10.1016\/j.nutres.2010.09.009_bb0400","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1111\/j.1572-0241.1999.01226.x","article-title":"Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients","volume":"94","author":"Dainese","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.nutres.2010.09.009_bb0405","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00042737-199805000-00011","article-title":"Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study","volume":"10","author":"Ragnarsson","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.nutres.2010.09.009_bb0410","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/gut.34.4.537","article-title":"Cephalic phase of colonic pressure response to food","volume":"34","author":"Rogers","year":"1993","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.nutres.2010.09.009_bb0415","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1053\/gast.2002.35394","article-title":"Lipid-induced intestinal gas retention in irritable bowel syndrome","volume":"123","author":"Serra","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.nutres.2010.09.009_bb0420","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00042737-199802000-00003","article-title":"Is coffee a colonic stimulant?","volume":"10","author":"Rao","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.nutres.2010.09.009_bb0425","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/humrep\/deh795","article-title":"Serum fluctuations of total and free tryptophan levels during the menstrual cycle are related to gonadotrophins and reflect brain serotonin utilization","volume":"20","author":"Carretti","year":"2005","journal-title":"Hum Reprod"}],"container-title":["Nutrition Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531710001843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531710001843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T16:22:01Z","timestamp":1740673321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0271531710001843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0271531710001843"],"URL":"https:\/\/doi.org\/10.1016\/j.nutres.2010.09.009","relation":{},"ISSN":["0271-5317"],"issn-type":[{"value":"0271-5317","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}